ES528761A0 - Procedimiento para preparar nuevos derivados de aminoacidos espirociclicos - Google Patents

Procedimiento para preparar nuevos derivados de aminoacidos espirociclicos

Info

Publication number
ES528761A0
ES528761A0 ES528761A ES528761A ES528761A0 ES 528761 A0 ES528761 A0 ES 528761A0 ES 528761 A ES528761 A ES 528761A ES 528761 A ES528761 A ES 528761A ES 528761 A0 ES528761 A0 ES 528761A0
Authority
ES
Spain
Prior art keywords
alkyl
denotes
aryl
denotes hydrogen
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES528761A
Other languages
English (en)
Other versions
ES8406880A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES8406880A1 publication Critical patent/ES8406880A1/es
Publication of ES528761A0 publication Critical patent/ES528761A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/96—Spiro-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyrrole Compounds (AREA)
ES528761A 1983-01-12 1984-01-10 Procedimiento para preparar nuevos derivados de aminoacidos espirociclicos Granted ES528761A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833300774 DE3300774A1 (de) 1983-01-12 1983-01-12 Neue spirocyclische aminosaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue spirocyclische aminosaeuren als zwischenprodukte und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
ES8406880A1 ES8406880A1 (es) 1984-09-01
ES528761A0 true ES528761A0 (es) 1984-09-01

Family

ID=6188100

Family Applications (2)

Application Number Title Priority Date Filing Date
ES528761A Granted ES528761A0 (es) 1983-01-12 1984-01-10 Procedimiento para preparar nuevos derivados de aminoacidos espirociclicos
ES530290A Expired ES8500905A1 (es) 1983-01-12 1984-03-05 Procedimiento para preparar derivados de aminoacidos espirociclicos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES530290A Expired ES8500905A1 (es) 1983-01-12 1984-03-05 Procedimiento para preparar derivados de aminoacidos espirociclicos.

Country Status (13)

Country Link
US (1) US4620012A (es)
EP (1) EP0116276B1 (es)
JP (1) JPH0759590B2 (es)
KR (1) KR910003185B1 (es)
AT (1) ATE39931T1 (es)
AU (1) AU575308B2 (es)
DE (2) DE3300774A1 (es)
DK (1) DK166586C (es)
ES (2) ES528761A0 (es)
GR (1) GR79158B (es)
IE (1) IE56544B1 (es)
PT (1) PT77943B (es)
ZA (1) ZA84213B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3226768A1 (de) * 1981-11-05 1983-05-26 Hoechst Ag, 6230 Frankfurt Derivate der cis, endo-2-azabicyclo-(3.3.0)-octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung
GR78413B (es) * 1981-12-29 1984-09-27 Hoechst Ag
US5175306A (en) * 1983-01-31 1992-12-29 Hoechst Aktiengesellschaft Process for the resolution of racemates of optically active bicyclic imino-α-carboxylic esters
DE3333455A1 (de) * 1983-09-16 1985-04-11 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung n-alkylierter dipeptide und deren estern
DE3413710A1 (de) * 1984-04-12 1985-10-24 Hoechst Ag, 6230 Frankfurt Verfahren zur behandlung der herzinsuffizienz
US5684016A (en) * 1984-04-12 1997-11-04 Hoechst Aktiengesellschaft Method of treating cardiac insufficiency
DE3431541A1 (de) * 1984-08-28 1986-03-06 Hoechst Ag, 6230 Frankfurt Cis,endo-2-azabicycloalkan-3-carbonsaeure-derivate, verfahren zu deren herstellung, deren verwendung sowie zwischenprodukte bei deren herstellung
WO1986007064A1 (en) * 1985-05-22 1986-12-04 Takeda Chemical Industries, Ltd. Piperidine derivatives
US5231080A (en) * 1985-10-15 1993-07-27 Hoechst Aktiengesellschaft Method for the treatment of atherosclerosis, thrombosis, and peripheral vessel disease
DE3610391A1 (de) * 1986-03-27 1987-10-08 Hoechst Ag Verbindungen mit nootroper wirkung, diese enthaltende mittel und deren verwendung bei der behandlung und prophylaxe cognitiver dysfunktionen
US5231084A (en) * 1986-03-27 1993-07-27 Hoechst Aktiengesellschaft Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons
CS277405B6 (en) * 1986-06-12 1993-03-17 Vyzk Ustav Farm Biochem Sp Peptides with 1-amino-1-cycloalkane carboxylic acid
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
DE3639879A1 (de) * 1986-11-21 1988-06-01 Hoechst Ag Verfahren zur herstellung von mono-, bi- und tricyclischen aminosaeuren, zwischenprodukte dieses verfahrens sowie ein verfahren zu deren herstellung
DE3722007A1 (de) * 1987-07-03 1989-01-12 Hoechst Ag Verfahren zur herstellung bicyclischer aminocarbonsaeuren, zwischenprodukte dieses verfahrens und deren verwendung
HU904967D0 (en) * 1988-04-22 1991-01-28 Hoechst Ag Process for producing new azabicyclo(3.3.o)octane-3-carboxylic acid-octylesther derivatives
ES2227896T3 (es) * 1997-12-16 2005-04-01 Warner-Lambert Company Llc Derivados de 1-aminometil-cicloalcanos sustituidos en 1 (=analogos de gabapentina), su preparacion y su uso en el tratamiento de trastornos neurologicos.
EP1615886A1 (en) * 2003-04-15 2006-01-18 Warner-Lambert Company LLC [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions
WO2004092132A1 (en) * 2003-04-15 2004-10-28 Warner-Lambert Company Llc [b]-fused bicyclic proline derivatives and their use for treating arthritic conditions
CN113372324A (zh) * 2021-06-18 2021-09-10 山东大学苏州研究院 一种通过碘化锂催化合成螺环类化合物的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
LU88621I2 (fr) * 1980-10-23 1995-09-01 Schering Corp Sandopril
DE3211397A1 (de) * 1982-03-27 1983-11-10 Hoechst Ag, 6230 Frankfurt Spiro (4.(3+n))-2-aza-3-carbonsaeure-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung

Also Published As

Publication number Publication date
US4620012A (en) 1986-10-28
KR840007585A (ko) 1984-12-08
DK166586B (da) 1993-06-14
DK166586C (da) 1993-11-08
DE3300774A1 (de) 1984-07-12
AU575308B2 (en) 1988-07-28
PT77943B (de) 1986-05-30
EP0116276B1 (de) 1989-01-11
ES8406880A1 (es) 1984-09-01
IE840048L (en) 1984-07-12
DK11984D0 (da) 1984-01-11
KR910003185B1 (ko) 1991-05-22
DK11984A (da) 1984-07-13
EP0116276A3 (en) 1985-11-27
JPH0759590B2 (ja) 1995-06-28
ES530290A0 (es) 1984-11-01
GR79158B (es) 1984-10-02
DE3476067D1 (en) 1989-02-16
ES8500905A1 (es) 1984-11-01
ATE39931T1 (de) 1989-01-15
EP0116276A2 (de) 1984-08-22
AU2322984A (en) 1984-07-19
PT77943A (de) 1984-02-01
IE56544B1 (en) 1991-08-28
JPS59134765A (ja) 1984-08-02
ZA84213B (en) 1984-08-29

Similar Documents

Publication Publication Date Title
ES534001A0 (es) Procedimiento para preparar derivados del acido 2-azabiciclo(3.1.0)hexan-3-carboxilico
ES530290A0 (es) Procedimiento para preparar derivados de aminoacidos espirociclicos.
ES8607281A1 (es) Procedimiento para la preparacion de nuevos derivados de aminoacidos biciclicos.
ES8500229A1 (es) Procedimiento para preparar derivados de aminoacidos triciclicos
MX7012A (es) Procedimiento para preparar derivados de acido-cis,endo-2-azabiciclo-(5.3.0.)-decan-3-carboxilico.
ES8404351A1 (es) Procedimiento para la preparacion de nuevos derivados de acido 2-aza-biciclo(2.2.2)octan-3-carboxilico
ES8501401A1 (es) Procedimiento para preparar nuevos derivados del azabiciclo heptano.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20041102